Somaxon Pharmaceuticals to Raise $3.0 Million in Registered Direct Offering
July 20, 2012 00:30 ET
|
Somaxon Pharmaceuticals, Inc.
SAN DIEGO, July 20, 2012 (GLOBE NEWSWIRE) -- Somaxon Pharmaceuticals, Inc. (Nasdaq:SOMX), a specialty pharmaceutical company, today announced that it has entered into definitive agreements to sell...
Somaxon Pharmaceuticals Announces Settlement of Silenor Patent Litigation With Zydus
July 19, 2012 08:00 ET
|
Somaxon Pharmaceuticals, Inc.
SAN DIEGO, July 19, 2012 (GLOBE NEWSWIRE) -- Somaxon Pharmaceuticals, Inc. (Nasdaq:SOMX), a specialty pharmaceutical company, today announced that it has entered into a settlement agreement with...
Somaxon Pharmaceuticals Announces Settlement of Silenor Patent Litigation With Mylan and PAR
July 17, 2012 16:05 ET
|
Somaxon Pharmaceuticals, Inc.
SAN DIEGO, July 17, 2012 (GLOBE NEWSWIRE) -- Somaxon Pharmaceuticals, Inc. (Nasdaq:SOMX), a specialty pharmaceutical company, today announced that it has entered into separate settlement arrangements...